We serve Calcium stearate CAS:1592-23-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Calcium content | 5.8%-7.2% | 6.5% |
| Free fatty acid (as stearic acid) | ≤0.5% | 0.38% |
| Heating loss | ≤3.0% | 1.9% |
| Fitness(pass 0.075mm sieve) | ≥99.0% | 99.2% |
| Melting point | ≥125℃ | 131.2℃ |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like Calcium stearate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,flexichem physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,flexichemcs Use and application,Octadecanoic acid, calcium salt technical grade,usp/ep/jp grade.
Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry.(3aR,6R,7R,7aS)-5-(4-Benzyloxy-benzenesulfonyl)-7-hydroxy-2,2-dimethyl-hexahydro-[1,3]dioxolo[4,5-c]pyridine-6-carboxylic acid methyl ester manufacturer “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.6,21-epoxy-21-hydroxy-17-methoxy-aspidospermidine-3-carboxylic acid methyl ester supplier Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.1H-Pyrrole-1-butanoic acid,3-[3-(decylamino)benzoyl]-4-(1-methylethyl)-, monosodium salt vendor That notice came two days after Chinese President Xi Jinping — a well known TCM advocate — called for the “combination of Chinese and Western medicine” in the diagnosis and treatment of the disease at a meeting of the Communist Party’s Politburo Standing Committee, the country’s supreme ruling body.The move could force international drugmakers to further cut prices and enable copycat medicines to replace imported off-patent brands at faster pace.
